Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024
During the summer of 2023, the European Region experienced a limited resurgence of mpox cases following the substantial outbreak in 2022. This increase was characterised by asynchronous and bimodal increases, with countries experiencing peaks at different times. The demographic profile of cases duri...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Instituto de Salud Carlos III (ISCIII) |
| Repositorio: | Repisalud |
| Idioma: | inglés |
| OAI Identifier: | oai:repisalud.isciii.es:20.500.12105/25436 |
| Acceso en línea: | https://hdl.handle.net/20.500.12105/25436 |
| Access Level: | acceso abierto |
| Palabra clave: | Europe MPXV Mpox WHO European Region Orthopoxvirus Outbreak Adolescent Adult Aged Child Child, Preschool Disease Outbreaks Female Humans Incidence Male Middle Aged Phylogeny Population Surveillance Young Adult |
| Sumario: | During the summer of 2023, the European Region experienced a limited resurgence of mpox cases following the substantial outbreak in 2022. This increase was characterised by asynchronous and bimodal increases, with countries experiencing peaks at different times. The demographic profile of cases during the resurgence was largely consistent with those reported previously. All available sequences from the European Region belonged to clade IIb. Sustained efforts are crucial to control and eventually eliminate mpox in the European Region. |
|---|